secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001770787-24-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics appoints Alan V. Mateo to Board of Directors
---------------------------------------------------------

- Alan V. Mateo appointed as Class II director effective June 18, 2024, term until 2027 annual meeting.
- Mateo previously Executive VP Global Sales at Veeva Systems, executive roles at Medidata Solutions and PeopleSoft.
- Receives $55k annual cash retainer, $400k initial RSU grant (July 31, 2024), and $215k annual RSU grant.
- Compensation includes standard indemnification agreement; eligible for additional committee service retainers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078724000044/0001770787-24-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078724000044/txg-20240618.htm
  HTML page:      https://secwatch.observer/filing/0001770787-24-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer